Seventeen strains of HS-producing variants of Escherichia coli were isolated from specimens submitted for microbiological study (ten from stool, five from urine, and two from postmortem material). Production of HS was unstable in several strains; however, other than their production of H2S, all strains closely resembled typical E. coli in their biochemical reactions. In vitro susceptibilities of the H2S-producing variants to antimicrobics closely resembled those of typical E. coli in this laboratory.
The biochemical and serological characteristics of hydrogen sulfide-producing (H2S-producing) variants of Escherichia coli have been recently described in detail by Darland and Davis (1) . Between 1970 and 1973, 17 such strains were isolated from clinical material at the Mayo Clinic. The clinical, biochemical, and antimicrobial susceptibility characteristics of these strains are reported here.
MATERIALS AND METHODS
Initial screening of gram-negative bacilli isolated from clinical specimens is accomplished in this laboratory by inoculation of a portion of an isolated colony into triple sugar-iron agar, lysine-iron agar, Simmons' citrate agar, Christensen's urea agar, ornithinemotility semisolid agar, and indole test broth (13) . Additional confirmatory tests are those described by Edwardsand Ewing (3) , and differentiation of the Enterobacteriaceae is based on the revised classification and nomenclature of Ewing (4) . Isolates of H2S-producing variants of E. coli conformed to the reactions described by Darland and Davis (1) .
Antimicrobial susceptibility testing of the isolates was performed by the agar-dilution procedure with an inocula-replicating apparatus as described by Steers et al. (10) and an expanded dilution scale as described by Washington (12) . The inoculum was adjusted so that 104 colony-forming units were delivered onto the agar surface.
The records of the patients from whom H2S-producing variants of E. coli were isolated were reviewed in an attempt to establish whether or not these isolates were clinically or epidemiologically significant.
RESULTS
The colonies ranged in size from 2 to 3.2 mm after 24 h of incubation. They appeared as glistening, grayish-white, convex colonies on 5% sheep blood agar after 24 h. On eosin-methylene blue agar the colonies were opaque and slightly purple with smooth edges; occasionally they had an undulate edge. A green metallic sheen became apparent at 24 to 48 h in the region of heavier inoculum.
The biochemical reactions of the 17 H2S-producing variants of E. coli are listed in Table 1 . Twelve strains produced an acidic slant and butt in triple sugar-iron agar; five produced an alkaline slant and acidic butt in this medium. None of the strains utilized citrate or malonate, hydrolyzed urea, deaminated lysine or phenylalanine, grew in KCN or on cetrimide, were Voges-Proskauer positive, liquified gelatin, or fermented inositol or adonitol. All produced HS in both triple sugar-iron agar and lysineiron agar, reduced nitrate, produced indole, were methyl red-positive, and fermented dextrose, arabinose, maltose, xylose, mannitol, and trehalose.
Antimicrobial susceptibilities are listed in Table 2 . All of the strains were susceptible to gentamicin, polymyxin B, kanamycin, streptomycin, chloramphenicol, nalidixic acid, and nitrofurantoin. Ampicillin, cephalothin, carbenicillin, and tetracycline exhibited moderate activity against these strains.
Ten of the isolates were from stool cultures, of which four were from patients with signs and symptoms of acute gastroenteritis and from whom no salmonellae or shigellae were isolated. None of these strains was tested for enterotoxin production or invasive properties. No clinical significance could be ascribed to the other stool isolates. Five isolates were from urine: in one case, in small numbers in mixed culture; in three cases, there was significant bacteriuria associated with signs and symptoms of urinary tract infection; and, in one case, the patient had (1) . Because of significant differences in some reactions and the distribution of 0 and H antigens between the variants and biochemically typical E. coli, these investigators thought that the variants represented a rather limited subgroup of E. coli. Some, but not all, of these differences were noted in our isolates and corroborate Darland and Davis's contention. These investigators noted pronounced differences in antimicrobial susceptibility between H2S-positive E. coli and biochemically typical E. coli. Many of the variants were resistant to tetracycline, sulfadiazine, streptomycin, and ampicillin, whereas few of their typical E. coli strains were. Our H2S-producing variants were slightly more resistant than our typical E. coli to ampicillin (59 and 71%, respectively, inhibited by 5 Atg/ml) and tetracycline (59 and 70%, respectively, inhibited by 5 og/ml) but were otherwise very similar in their susceptibilities to the other antimicrobics tested. Close linkage between the gene responsible for H2S production and tetracycline resistance has been reported (11) .
Instability of H2S production, a characteristic noted in several of our strains, has been reported by other investigators (1, 5, 8, 9) . This instability may limit recognition of the variant in clinical material.
The clinical significance of H2S-producing variants of E. coli remains unclear. The ability of the organism to produce H2S appears to be mediated by extrachromosomal deoxyribonucleic acid (9) , as are hemolysins, colicins, and plasmids for drug resistance and enterotoxin. It is conceivable, therefore, that a plasmid that mediates drug resistance or enterotoxin production can become linked with H2S production. Enterotoxigenicity by strains of'E. coli (2) and other Enterobacteriaceae (7) is now well known, as is the high rate of transfer (6) . Unfortunately, none of our isolates were tested for this property, so that their role in producing gastroenteritis could not be assessed. That they are capable of causing significant bacteriuria seems clear. Their role in producing terminal infections in the two patients who died is not at all clear, because the clinical significance of postmortem bacteriology is highly questionable (14) .
